Terms: = Germ cell tumor AND MALAT1, PRO1073, 378938, Q9UHZ2
69 results:
1. Insights into the roles of non-coding RNAs and angiogenesis in glioblastoma: An overview of current research and future perspectives.
Song Z; Xue Z; Wang Y; Imran M; Assiri M; Fahad S
Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130567. PubMed ID: 38242182
[TBL] [Abstract] [Full Text] [Related]
2. Concurrent presence of diabetes affects the GLUT3 programming of glucose metabolism in glioblastoma.
Kocaeli AA; Tekin C; Ercelik M; Tezcan G; Aksoy SA; Kocaeli H; Bekar A; Taskapilioglu MO; Tolunay S; Tunca B
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):8110-8118. PubMed ID: 37750639
[TBL] [Abstract] [Full Text] [Related]
3. MDMA targets miR-124/MEKK3 via malat1 to promote Parkinson's disease progression.
Geng X; Li S; Li J; Qi R; Zhong L; Yu H
Mol Biol Rep; 2023 Nov; 50(11):8889-8899. PubMed ID: 37688681
[TBL] [Abstract] [Full Text] [Related]
4. Deconstructing the role of malat1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment.
Feichtenschlager V; Zheng YJ; Ho W; Chen L; Callanan C; Chen C; Lee A; Ortiz J; Rappersberger K; Ortiz-Urda S
Oncotarget; 2023 May; 14():543-560. PubMed ID: 37235843
[TBL] [Abstract] [Full Text] [Related]
5. Diabetes Mellitus-Mediated malat1 Expression Induces Glioblastoma Aggressiveness.
Kocaeli AA; Aksoy SA; Ercelik M; Tezcan G; Tekin C; Kocaeli H; Bekar A; Taskapilioglu MO; Tolunay S; Tunca B
Turk Neurosurg; 2023; 33(5):821-827. PubMed ID: 37144653
[TBL] [Abstract] [Full Text] [Related]
6. Influence of the Cultivation Conditions of the Glioblastoma Neurosphere on the Expression of malat1 and LINCROR Long Non-coding RNA Genes.
Mazur DV; Mishanova AV; Kovalenko TF; Shakhparonov MI; Antipova NV
Dokl Biochem Biophys; 2023 Feb; 508(1):21-24. PubMed ID: 36653583
[TBL] [Abstract] [Full Text] [Related]
7. Identification and comparison of m6A modifications in glioblastoma non-coding RNAs with MeRIP-seq and Nanopore dRNA-seq.
Krusnauskas R; Stakaitis R; Steponaitis G; Almstrup K; Vaitkiene P
Epigenetics; 2023 Dec; 18(1):2163365. PubMed ID: 36597408
[TBL] [Abstract] [Full Text] [Related]
8. The long noncoding RNA malat1/microRNA-598-3p axis regulates the proliferation and apoptosis of retinoblastoma cells through the PI3K/AKT pathway.
Lin X; Huang X; Wang L; Liu W
Mol Vis; 2022; 28():269-279. PubMed ID: 36284668
[TBL] [Abstract] [Full Text] [Related]
9. Integrated analysis to reveal potential therapeutic targets and prognostic biomarkers of skin cutaneous melanoma.
Zhou X; Rong R; Xiong S; Song W; Ji D; Xia X
Front Immunol; 2022; 13():914108. PubMed ID: 36032150
[TBL] [Abstract] [Full Text] [Related]
10. The evaluation expression of non-coding RNAs in response to HSV-G47∆ oncolytic virus infection in glioblastoma multiforme cancer stem cells.
Vazifehmand R; Ali DS; Othman Z; Chau DM; Stanslas J; Shafa M; Sekawi Z
J Neurovirol; 2022 Dec; 28(4-6):566-582. PubMed ID: 35951174
[TBL] [Abstract] [Full Text] [Related]
11. Long non-coding RNA panel as a molecular biomarker in glioma.
Ebrahimi AA; Ashoori H; Vahidian F; Mosleh IS; Kamian S
J Egypt Natl Canc Inst; 2021 Oct; 33(1):31. PubMed ID: 34693506
[TBL] [Abstract] [Full Text] [Related]
12. Integrated Bioinformatic Analysis of Competing Endogenous RNA Network of Choriocarcinoma.
Tan Q; Tan Z; Liu J; Mo Y; Liu H
Med Sci Monit; 2021 Sep; 27():e931475. PubMed ID: 34538870
[TBL] [Abstract] [Full Text] [Related]
13. Long non-coding RNAs as a predictive markers of group 3 medulloblastomas.
Mutlu M; Tekin C; Ak Aksoy S; Taskapilioglu MO; Kaya S; Balcin RN; Ocak PE; Kocaeli H; Bekar A; Tolunay S; Tunca B
Neurol Res; 2022 Mar; 44(3):232-241. PubMed ID: 34533098
[TBL] [Abstract] [Full Text] [Related]
14. LncRNA expression and SDHB mutations in pheochromocytomas and paragangliomas.
Li H; Hardin H; Zaeem M; Huang W; Hu R; Lloyd RV
Ann Diagn Pathol; 2021 Dec; 55():151801. PubMed ID: 34461576
[TBL] [Abstract] [Full Text] [Related]
15. Weighted genes associated with the progression of retinoblastoma: Evidence from bioinformatic analysis.
Zhou W; Guan W; Zhou Y; Rao Y; Ji X; Li J
Exp Eye Res; 2021 Oct; 211():108730. PubMed ID: 34419445
[TBL] [Abstract] [Full Text] [Related]
16. LncRNA malat1 promotes glioma cell growth through sponge miR-613.
Su Y; Liang C; Yang Q
J BUON; 2021; 26(3):984-991. PubMed ID: 34268963
[TBL] [Abstract] [Full Text] [Related]
17. Genomic analyses of high-grade neuroendocrine gynecological malignancies reveal a unique mutational landscape and therapeutic vulnerabilities.
Mahdi H; Joehlin-Price A; Elishaev E; Dowlati A; Abbas A
Mol Oncol; 2021 Dec; 15(12):3545-3558. PubMed ID: 34245124
[TBL] [Abstract] [Full Text] [Related]
18. Coexistence of TERT C228T mutation and malat1 dysregulation in primary glioblastoma: new prognostic and therapeutic targets.
Ak Aksoy S; Mutlu M; Tunca B; Kocaeli H; Taskapilioglu MO; Bekar A; Tekin C; Argadal OG; Civan MN; Kaya İS; Ocak PE; Tolunay S
Neurol Res; 2021 Nov; 43(11):916-925. PubMed ID: 34210246
[No Abstract] [Full Text] [Related]
19. METTL3 enhances the stability of malat1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.
Chang YZ; Chai RC; Pang B; Chang X; An SY; Zhang KN; Jiang T; Wang YZ
Cancer Lett; 2021 Jul; 511():36-46. PubMed ID: 33933553
[TBL] [Abstract] [Full Text] [Related]
20. RMRP, RMST, FTX and IPW: novel potential long non-coding RNAs in medullary thyroid cancer.
Luzón-Toro B; Villalba-Benito L; Fernández RM; Torroglosa A; Antiñolo G; Borrego S
Orphanet J Rare Dis; 2021 Jan; 16(1):4. PubMed ID: 33407723
[TBL] [Abstract] [Full Text] [Related]
[Next]
